Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Biochemical Reagents
  4. Peptides
  5. NB398633

Novus Biologicals™ p14ARF/CDKN2A Antibody Blocking Peptide
SDP

Catalog No. NB398633 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398633 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398633 Supplier Novus Biologicals™ Supplier No. NB11059085PEP
Only null left
Add to Cart
Add to Cart

Specifications

Gene ID (Entrez) 1029
Concentration 1 mg/mL
Content And Storage Store at -80°C. Avoid freeze/thaw cycles.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB110-59085
Gene Alias ARF, CDK4 inhibitor p16-INK4, CDK4IP14ARF, CDKN2, cell cycle negative regulator beta, CMM2P16-INK4A, Cyclin-dependent kinase 4 inhibitor A, cyclin-dependent kinase inhibitor 2 A, cyclin-dependent kinase inhibitor 2 A (melanoma, p16, inhibits CDK4), INK4, INK4A, MLMP16INK4, MTS-1, MTS1P14, Multiple tumor suppressor 1, p14, p14ARF, p16, p16-INK4, p16INK4a, p16-INK4a, P19, p19ARF, TP16
Gene Symbol CDKN2A
Quantity 0.1 mg
Research Category ABC Transporters, Biologically Active Proteins, Cancer, Cell Biology, Cell Cycle and Replication, Chromatin Research, DNA Repair, Hypoxia, MAP Kinase Signaling, Neuroscience, p53 Pathway, Transcription Factors and Regulators, Tumor Suppressors
Storage Buffer Peptide dissolved in dH20. Contains no BSA.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.